Fructus Xanthii and Magnolia liliiflora Volatile Oils Liposomes-Loaded Thermosensitive in situ Gel for Allergic Rhinitis Management
Zhongxu Jing,Wenqing Li,Wei Liao,Ying Lv,Yuwei Liu,Haibo Jiang,Yufei Feng
DOI: https://doi.org/10.2147/ijn.s445240
IF: 7.033
2024-02-19
International Journal of Nanomedicine
Abstract:Zhongxu Jing, &ast Wenqing Li, &ast Wei Liao, Ying Lv, Yuwei Liu, Haibo Jiang, Yufei Feng Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, 150040, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yufei Feng, Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Harbin, 150040, People's Republic of China, Tel +86-18503653988, Email Purpose: The aim of the present study was to fabricate a Fructus Xanthii and Magnolia liliiflora volatile oils liposomes-loaded thermosensitive in situ gel (gel/LIP/volatile oil) for effectively treating allergic rhinitis via intranasal administration. Patients and Methods: Particle size, polymer dispersity index (PDI), entrapment effectiveness, and cumulative drug permeation of the developed liposomes were assessed. Then, a thermoreversible in situ gel was created using the liposomes loaded with volatile oils of Fructus Xanthii and Magnolia liliiflora . The effectiveness of this treatment for allergic rhinitis was confirmed by evaluating nasal symptoms, and hematological results, after injecting the formulation into the ovalbumin (OVA)-sensitized mice, we conducted hematoxylin-eosin staining (HE) and immunohistochemistry to evaluate the outcomes. The effects of the gel/LIP/volatile oil formulation for nasal delivery of volatile oil in the treatment of rhinitis were then assessed. Results: The average particle size was 95.1 ± 3.6 nm, and the encapsulation efficiencies of Fructus Xanthii and Magnolia liliiflora volatile oils were 70.42 ± 5.41% and 67.10 ± 6.08%, respectively. Drug loadings of Fructus Xanthii and Magnolia liliiflora volatile oils were 9.10 ± 0.98% and 16.10 ± 1.03%, respectively. The binary formulation produced a gel rapidly in the nasal cavity with a strong mucosal adherence at a temperature of delivering volatile oil to the nasal mucosa steadily and continuously. After nasal administration, the gel/LIP/volatile oil sustained the volatile oil delivery into the mucosa. In comparison to the monolithic formulations, the gel/LIP/volatile oil binary formulation exhibited superior performance in terms of drug delivery capability and pharmacodynamic effects. Conclusion: This binary preparation displayed the ability to deliver drugs to the nasal mucosa and exhibited positive pharmacodynamic effects in treating OVA-induced rhinitis in mice. As a result, it has the potential to serve as a delivery platform for Traditional Chinese medicine in the treatment of allergic rhinitis. Keywords: volatile oil of Magnolia liliiflora , volatile oil of Fructus Xanthii , liposomes, thermosensitive gel, allergic rhinitis Allergic rhinitis (AR) is a highly prevalent chronic condition that impacts 400 million individuals globally and 100 million people in Europe. 1,2 Intranasal glucocorticoids, antihistamines, and disodium cromoglycate are all viable pharmaceutical therapy choices. Antihistamine sedation, disodium cromoglycate nasal mucosal irritation, and candidiasis are a few of the moderate side effects of these corticosteroid drugs. Traditional Chinese medicine (TCM) for treating AR has several clear benefits. Recently, some studies have demonstrated effectiveness in managing the AR and immunological functions of the body. 3–5 Some AR patients favor TCM treatments. 6 Fructus Xanthii powder is recorded in "Ji Sheng Fang" and is composed of Fructus Xanthii, Magnolia liliiflora, Angelica dahurica , and mint. It was considered by Chinese doctors of all dynasties to be the main prescription formulation for treating nasal diseases, and Fructus Xanthii was the "monarch's medicine", while Magnolia liliiflora was the minister's medicine in "Ji Sheng Fang". 7 Fructus Xanthii is a dried and ripe fruit with the involucre of Xanthium sibiricum Patr., Magnolia liliiflora consists of volatile oils and sesquiterpene lactones. It is included in the 20th edition of Chinese Pharmacopoeia, that volatile oils are the main pharmacodynamic components in Fructus Xanthii and Magnolia liliiflora . 8,9 Studies have confirmed that both TCMS have anti-inflammatory, anti-allergic, and antihistamine effects. At the same time, their compatibility can reduce Fructus Xanthii toxicity and enhance its anti-inflammatory effects, have the effect of rapidly relieving nasal congestion symptoms, and treat AR with multi-target and multi-pathway regulation. 10,11 Nasal medication delivery methods have the pot -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology